HORMONE THERAPY IN AGING MALE ATHLETES

Similar documents
An Idea Whose Time Has Come-Male Health Programs: An Opportunity For Clinical Expansion and Better Health

TESTOSTERONE DEFINITION

Point-Counterpoint: Late Onset Hypogonadism (LOH)

Evaluation and Treatment of Primary Androgen Deficiency Syndrome in Male Patients

Prof Dato Dr TAN Hui Meng University of Malaya, Kuala Lumpur University of Pennsylvania, USA

Hormone Replacement Therapy

What Is the Low T Syndrome? Is Testosterone Supplementation Safe?

PCa Commentary. Prostate Cancer? Where's the Meat? - A Collection of Studies Supporting the Safety of Its Use. Seattle Prostate Institute CONTENTS

Consent for Testosterone Therapy-Men Revised 4/10/18

Testosterone Therapy in Men An update

Hypogonadism 4/27/2018. Male Hypogonadism -- Definition. Epidemiology. Objectives HYPOGONADISM. Men with Hypogonadism. 95% untreated.

Late onset Hypogonadism. Dr KhooSay Chuan Department of Urology Penang General Hospital

Corporate Medical Policy Testosterone Pellet Implantation for Androgen Deficiency

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Hormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase

10 Essential Blood Tests PART 2

Take-Home Messages: Androgens

Disclosures. Faculty 3/5/18. Testosterone, the FDA and CVD Risk Controversies. Matt Rosenberg, MD Director of Mid-Michigan Health Centers Jackson, MI

66 M with erectile dysfunction and abnormal labs RAJESH JAIN ENDORAMA 10/29/2015

Testosterone: Current Opinion and Controversy

Men Getting Older Will Testosterone Keep Him Young?

SMSNA Hypogonadism Colloquium: Update

An Update on Men s Health and Sexual Function

The Male Andropause. What are the symptoms? What are the risks of hormone deficiencies?

Disclosures. Learning Objectives. Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease. None

Recognizing and Managing Testosterone Deficiency

Testosterone Therapy in Men with Hypogonadism

HYPOGONADISM DEFINITION: PRODUCTION OF SEX HORMONES AND GERM CELLS IS INADEQUATE (ENDOCRINE SOCIETY)

Implantable Hormone Pellets

Where are the injections given? They are given in the upper outer hip.

One Day Hormone Check

6/14/2010. GnRH=Gonadotropin-Releasing Hormone.

Naviga2ng the Adverse Effects of ADT: Improving Pa2ent Outcomes

Endocrine Update Mary T. Korytkowski MD Division of Endocrinology University of Pittsburgh

ISSM QUICK REFERENCE GUIDE ON TESTOSTERONE DEFICIENCY FOR MEN

One Day Hormone Check

Definition of Andropause

GUIDELINES ON. Introduction. G.R. Dohle, S. Arver, C. Bettocchi, S. Kliesch, M. Punab, W. de Ronde

THINGS ARE NOT ALWAYS AS THEY APPEAR. Assume Nothing!

Mechanism: How ADT accelerates CVD?

Late onset hypogonadism

Estrogens vs Testosterone for cardiovascular health and longevity

Testosterone and PDE5 inhibitors in the aging male

Implantable Hormone Pellets

An Evidence-based Review of Clinical Trial Data

TESTOSTERONE REPLACEMENT THERAPY. WHAT IS THE REAL RISK? WHAT TO DO IN PROSTATE CANCER?

Testosterone Treatment: Myths Vs Reality. Fadi Al-Khayer, M.D, F.A.C.E

Hormones Nuts and Bolts. Ron Rothenberg MD

Update on diagnosis and complications of adult and elderly male hypogonadism

UPDATE: Women s Health Issues

Testosterone and the Prostate

Diagnosis and Clinical Evaluation of Hypogonadism in Adult Patients with Obesity and Diabetes

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

Managing Testosterone Deficiency: A Practical Guide. John Grantmyre MD Professor of Urology Dalhousie University

Testosterone Therapy and the Prostate. Frans M.J. Debruyne Professor of Urology The Netherlands

Androderm patch, AndroGel packets and pump, Axiron solution, First- Testosterone, First-Testosterone MC, Fortesta gel, Testim gel, Vogelxo

Hypogonadism in Men. CME Away India & Sri Lanka March 23 - April 7, 2018

Therapeutic Cohort Results

Recommendations on the diagnosis, treatment and monitoring of Testosterone deficiency (TD) in adult men

Male Menopause Avoiding andropause with testosterone treatment By Edward D. Rosick

EFFICACY AND SAFETY OF TESTOSTERONE THERAPY FOR LATE-ONSET HYPOGONADISM: AN UPDATE

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Does TRT Induce Prostate Cancer?

THE RELEVANCE OF TESTOSTERONE THERAPY IN MANAGING PATIENTS WITH ERECTILE DYSFUNCTION

Therapeutic Cohort Results

Erectile Dysfunction, Cardiovascular Risk and

Low Testosterone Consultation Information

Therapeutic Cohort Results

How Long Does It Take For Testosterone Replacement Therapy to Work?

Advisory Committee Industry Briefing Document. Testosterone Replacement Therapy

Current Topics in Hormone Replacement Therapy

R. Charles Welliver, Jr.,* Herbert J. Wiser, Robert E. Brannigan, Kendall Feia, Manoj Monga and Tobias S. K ohler

A dro r gen e R e R p e lac a e c m e e m n e t t T her e a r p a y Androgen Replacement Therapy in the Aging O j b ecti t ve v s Male

Disclosures. Advisory Boards 6/10/2014

Hormone Replacement Therapy For Men Consultation Information

PRISM Bruges June Herman Leliefeld Urologist. The Netherlands

Androgen deficiency. Dr Rakesh Iyer Staff Specialist in Endocrinology Calvary hospital

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

GUIDELINES ON MALE HYPOGONADISM

Male New Patient Package

EAU GUIDELINES ON MALE HYPOGONADISM

The Sexual Medicine Society of North. Adult-Onset Hypogonadism SPECIAL ARTICLE

Marketing Authorisation Holder Applicant Invented name. Route of administration. Content (concentration) Member State. l form

How to treat: TRT modalities and formulations

Testosterone Injection and Implant

Tobias S. Kohler, MD, MPH, FACS Southern Illinois University School of Medicine AUA SMSNA Program May 7, 2016

JAMA. 2011;305(24): Nora A. Kalagi, MSc

Testosterone Replacement Therapy for Hypogonadism: Learning Objectives. What Is the Evidence? Is It Safe? Case Study. Case Study contd.

Male Menopause: Disease or Pseudoscience? March 4, 2015 story: FDA to require warning on labels of testosterone products.

MATERIALS AND METHODS

Update on Androgen Deficiency. Acknowledgments. Curatio PowerPoint TemplateControversies in Male Hypogonadism Bradley D.

25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?

Guidelines for the Clinical Care of Persons with Gender Dysphoria

EVALUATION AND MANAGEMENT OF TESTOSTERONE DEFICIENCY: AUA GUIDELINE

FAILURE IS NOT AN OPTION HOPE IS NOT A PLAN

Guidelines for the Clinical Care of Persons with Gender Dysphoria

EAU GUIDELINES ON MALE HYPOGONADISM

Hormonal Alterations in Heart Failure: Anabolic Impairment in Chronic Heart Failure Diagnostic, Prognostic and Therapeutic Issues

presents with Ken Sekine, MD

in Primary Care (Part 2) Jonathan R. Anolik, MD, FACP, FACE Lewis Katz School of Medicine at Temple University

Transcription:

DISCLOSURES HORMONE THERAPY IN AGING MALE ATHLETES No relevant affiliations or financial interests When, Why and is it Safe? OBJECTIVES Summarize the benefits of optimizing hormone balance Examine the risks and controversies surrounding testosterone therapy Discuss monitoring and managing therapy for maximum benefit AGING the fundamental manifestation of aging is an overall decline in the functional capacity of various organs to maintain tissue homeostasis and to respond adequately to physiological needs under stress. Kirkland, TB, Understanding the odd science of aging, Cell 120, 437 447 (2005) SUCCESSFUL AGING Low probability of disease and disease related disability High cognitive and physical functional capacity Active engagement with life JW Rowe & RL Kahn, Successful Aging, The Gerantologist, vol 37, no. 4, pg 433 440, 1997 Jack Lalanne 1

INFORMED CHOICES FUTURE VISION LIFE YOU WANT TO LIVE Generally oxygen uptake declines 10 15% per decade after age 20 An accumulation of body fat and a decrease in habitual physical activity accounts for about half of that age related decrease. Calvo JA, Daniels, TG, et al. Muscle specific expression of PPAR(gamma) coactivator1(alpha) improves exercise performance and peak oxygen uptake. J Appl Physio 2008; 104:1304 1312 SARCOPENIA AGING ATHLETE Largest loss of muscle mass occurs between age 50 75 Decline in anabolic hormones loss of muscle mass Muscles Ligaments Tendons J. 2013 Oct Dec; 3(4): 346 350 reduced strength reduced aerobic capacity diminished performance ANABOLIC HORMONES Testosterone Increases lean muscle Reduces body fat Improves cognition Enhances sex drive Improves erectile quality Increases energy Enhances mood and wellbeing HGH Increases lean muscle Reduces body fat (VAT) Improves sexual desire Increases bone density Improves skin elasticity Enhances mood Up to 1 in 3.5 men over 50 will suffer a fracture due to osteoporosis 2

CONTROVERSY: PROSTATE CANCER RISK Age associated decline in anabolic hormone levels (testosterone, DHEA and growth hormone) is a strong predictor of mortality in older men. withholding of testosterone replacement therapy in men because of fear of prostate cancer risk or progression is no longer tenable in an age of evidence based medicine, because neither evidence nor theory supports this position. Maggio M, Lauretani F, et al, Relationship Between Low Levels of Anabolic Hormones and 6 Year Mortality in Older Men Arch Intern Med. 2007;167(20):2249 2254. doi:10.1001/archinte.167.20.2249 Morgantaler A, meta analysis Harvard University, 2007 PILOT STUDY: TESTOSTERONE IN ADVANCED PROSTATE CANCER All patients reported symptomatic benefits, including improved energy, cognition, libido, sexual function, and sense of well being. There were no cases of disease flare, acute pain, or vertebral collapse. Sexual Medicine Society of North America (SMSNA) Fall 2017 Scientific Meeting. Abstracts 132 and 340. Presented October 26, 2017. CONTROVERSY: CARDIAC RISK In 2014, two methodologically flawed retrospective studies suggested an increased CV risk associated with testosterone therapy FDA issued a drug safety alert Results are contradicted by dozens of studies showing CV benefits testosterone therapy, or higher endogenous levels, including placebo controlled studies in men with known heart disease Morgentaler, A. Controversies and advances with testosterone therapy: A 40 Year Perspective. TESTOTERONE LOWERS CVD RISK 83,000 veterans, 3 groups: Rx/normal, Rx/low, non Rx/low Normalization of TT levels after TRT was associated with a significant reduction in all cause mortality, MI and stroke Treated men were 56% less likely to die, 24% less likely to have an MI and 36% less likely to have a stroke Journal of cardiovascular pharmacology and therapeutics. 2017:epub. Traish A, Haider A, Haider K, Doros G, Saad F Sharma, R. et al. (2015). Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. European Heart Journal. 3

TESTOSTERONE THERAPY IS SAFE AND EFFECTIVE We agree with the current opinions of the AACE/ACE as well as the international expert consensus panel that testosterone treatment should be considered for symptomatic men with clinically confirmed hypogonadism. The benefits of treatment of low testosterone levels with testosterone therapy in men and women substantially outweigh any risks, according to the current data. HOW TO DIAGNOSE LOW T Rigid interpretation of testosterone ranges should not dictate clinical decision making Give equivalent weight to signs and symptoms of hypogonadism and to laboratory assessment Elagizi A, Kohler T, Lavie C, Testosterone and Cardiovascular Health, Mayo Clinic Proceedings, Jan 2018 Bankhead, C (2014). Need more than Lab Test to determine Low T. Urology. TESTOSTERONE RANGES GRADE TOTAL TESTOSTERONE (ng/dl) A > 900 >150 FREE TESTOSTERONE (pg/ml) B 650 900 110 150 C 450 650 70 110 D 250 450 35 70 F < 250 < 35 ANDROGEN ASSAYS Though laboratory assays can support a diagnosis of androgen deficiency in men, they should not be used to exclude it. There needs to be greater reliance on the history and clinical features and where necessary a therapeutic trial of androgen treatment given Carruthers, Trinick, Wheeler (2007). The validity of androgen assays. The Aging Male. 10 (3) p. 165 172. TESTOSTERONE METABOLISM ESSENTIAL LABS TO EVALUATE LOW T DHEA 5 alpha reductase DHT Androstenidione Testosterone aromatase Estradiol Testosterone, free and total Dihydrotestosterone (DHT) Estradiol DHEA S Sex Hormone Binding Globulin (SHBG) CBC Luteinizing Hormone (LH) Prolactin 4

Therapy Options Testosterone Injections Topical Pellets HCG Clomid 51 YEAR OLD HOCKEY PLAYER Total T (mg/dl) Free T (pg/ml) VO2 (ml/kg/min) Lean (lbs) Body Fat% Before 214 44 33.1 152 27 1yr later 908 230 43.5 164 14 KEY TAKEAWAYS Hormone therapy can improve performance, reduce disease risk and premature death. Testosterone therapy is safe and effective Signs and symptoms should carry an equivalent weight to lab analysis in clinical decision making Enhancing performance is the best method for optimizing your personal health and well being, achieving your goals and living your life as the best version of yourself 5

Thank You www.alternityhealthcare.com 860.561.2294 6